Read More     [[{“value”:”An initiative entitled “greener pharmaceuticals’ regulatory highway” underscores the urgent need for innovative regulatory practices to reduce the environmental footprint of medical products while maintaining high standards of safety and efficacy. The World Health Organization (WHO), through its Department of Regulation and Prequalification, has issued a call for action to drive sustainability in the pharmaceutical sector.  “Addressing
The post Greener pharmaceuticals’ regulatory highway initiative aims to cut environmental footprint of medical products appeared first on Csr Egypt.”}]]